Cytogenetic Study of Ocular Melanoma

Jonsson Comprehensive Cancer Center95 enrolled

Overview

Patients who are diagnosed with choroidal melanoma and undergo I-125 plaque or enucleation surgery consent to participate in the study. A tumor sample taken during surgery is studied in the lab for genetic features. These features and features of subjects' clinical course are recorded. Analysis of the data may identify genetic features that are indicative of prognostic factors including risk of metastasis.

The Jules Stein Eye Institute Ocular Melanoma Research Group is conducting cytogenetic studies of choroidal melanoma to improve the screening of biopsy samples of choroidal melanoma through cytogenetic analysis. Our goal is to identify molecular probes that specifically target regions of chromosomes that undergo changes characteristic of metastatic choroidal melanoma.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Choroidal Melanoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patient with diagnosis of ocular melanoma 2. Patient with local treatment plan for ocular melanoma- plaque brachytherapy or enucleation 3. Patient 18 years of age or older 4. Archival enucleation specimens with diagnosis of ocular melanoma Exclusion Criteria: 1. Patient who refuses local melanoma treatment 2. Patient who refuses to participate in this study

Locations (1)

Jules Stein Eye Institute

Los Angeles, California, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.